Glucagon-like Peptide-1 Receptor Agonist Impact on Chronic Ocular Disease Including Age-Related Macular Degeneration
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Julia H. Joo (ORCID: https://orcid.org/0009-0000-1299-8144)
- Kevin Allan (ORCID: https://orcid.org/0000-0002-4206-9781)
- Aleksandra Rachitskaya (ORCID: https://orcid.org/0000-0001-5545-9474)
- David C. Kaelber (ORCID: https://orcid.org/0000-0001-7855-9515)
- Sonia Kim (ORCID: https://orcid.org/0009-0002-4827-6906)
- Rishi P. Singh (ORCID: https://orcid.org/0000-0001-5859-8162)
- Jacqueline K. Shaia (ORCID: https://orcid.org/0000-0001-7873-669X)
- Katherine E. Talcott (ORCID: https://orcid.org/0000-0003-0458-4181)
Institutions
- Cleveland Clinic Lerner College of Medicine (US)
- MetroHealth Medical Center (US)
- Cleveland Eye Clinic (US)
Publication Details
- Journal
- Ophthalmology
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1016/j.ophtha.2025.01.016
- Citations
- 31
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 40.14